MetaCap

Globus Medical Financial Ratios

NYSE: GMEDHealth CareMedical/Dental InstrumentsUSD

74.65+1.32 (+1.80%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Globus Medical ratio analysis

Globus Medical earned a net margin of 18.3% in FY 2025, up from 4.1% a year earlier. Gross margin was 67.4% compared with a median of 75.0% over the prior 9 years. Return on equity reached 11.8%, meaning Globus Medical generated 0.12 dollars of profit for every dollar of shareholders' equity.

At the end of FY 2025, GMED traded at 22.3 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 22.3 to 110.4, with a median of 39.3. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Globus Medical financial ratios (annual)

Globus Medical annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)22.27110.3949.8040.1550.1464.5738.3725.9737.3622.97
Price / sales4.024.463.847.307.598.157.365.496.224.21
Price / book2.582.691.514.044.184.274.123.304.092.85
Gross margin67.4%58.9%65.1%74.2%75.0%72.4%77.1%77.6%76.3%76.1%
Operating margin16.3%6.6%8.5%22.3%17.9%14.1%21.9%23.7%25.4%27.3%
Net margin18.3%4.1%7.8%18.6%15.6%13.0%19.8%21.9%16.9%18.5%
Free cash flow margin20.0%16.1%10.5%10.2%22.9%17.1%12.9%17.1%16.9%19.0%
Return on equity (ROE)11.8%2.5%3.1%10.3%8.6%6.8%11.1%13.2%11.1%12.5%
Return on assets (ROA)10.1%2.0%2.4%9.2%7.6%6.1%10.1%12.0%10.0%11.2%
Current ratio4.262.544.886.186.176.806.176.566.676.43
Revenue growth16.7%60.6%53.3%6.8%21.4%0.5%10.2%12.1%12.8%3.5%
EPS growth422.7%-29.9%-42.2%28.5%42.6%-33.6%-1.3%40.0%1.9%-7.7%

Related